President & Chief Business Officer
haematology
Valneva
Austria
Franck Grimaud was appointed President and Chief Business Officer (CBO) of Valneva. He co-founded Vivalis in 1999 serving as its CEO and “President du Directoire”. He has a long management track record, with more than 20 years of experience in various industries, including 14 years in the biopharmaceutical sector. Before building up Vivalis he was responsible for the creation of the Chinese, Malaysian and Thailand subsidiaries of Groupe Grimaud, a worldwide leader in animal genetic selection and currently Valneva’s largest shareholder. Franck Grimaud holds an MBA from the University of Ottawa (Canada).
research interest in mainly haematology department